Innovative Tools to Improve Colorectal Cancer Screening Rates in Manitoba
Colorectal Cancer
About this trial
This is an interventional screening trial for Colorectal Cancer focused on measuring colorectal cancer, screening, fecal occult blood test, randomized control trial, primary care oncology, web site, provincial health contact center
Eligibility Criteria
Inclusion Criteria:
- Average risk men and women
- between the ages of 50 to 74 years
- no symptoms of colorectal cancer
- no personal history of colorectal cancer, polyps or diseases of the colon requiring monitoring by colonoscopy
- includes individuals with one first degree relative with cancer of adenomatous polyps affected at age greater than 60 or two or more second degree relatives with polyps or cancer
Exclusion Criteria:
- walk-in patients
- patients having had a flexible sigmoidoscopy or double contrast barium enema within the last 5 years
- patients having had a colonoscopy within the last 10 years.
Sites / Locations
- University of Manitoba
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
FOBT by laboratory requisition or directly by PCP
FOBT by lab req. or directly from PCP + study magnet
The family physician indicates fecal occult blood test on the patient's laboratory requisition (i.e. the patient receives the fecal occult blood test at the lab) or provides the patient with an FOBT kit.
The family physician indicates fecal occult blood test on the patient's laboratory requisition (i.e. the patient receives the fecal occult blood test at the lab) or provides the patient with an FOBT kit. The family physician provides each patient with a study magnet containing a PHCC telephone number and study specific website address.